Is inflammatory micronucleation the key to a successful anti-mitotic cancer drug?
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Is inflammatory micronucleation the key to a successful anti-mitotic cancer drug?
Authors
Keywords
-
Journal
Open Biology
Volume 7, Issue 11, Pages 170182
Publisher
The Royal Society
Online
2017-11-15
DOI
10.1098/rsob.170182
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cell death response to anti-mitotic drug treatment in cell culture, mouse tumor model and the clinic
- (2017) Jue Shi et al. ENDOCRINE-RELATED CANCER
- Consequences of mitotic slippage for antimicrotubule drug therapy
- (2017) Bing Cheng et al. ENDOCRINE-RELATED CANCER
- Cytosolic nucleic acid sensors and innate immune regulation
- (2017) Daisuke Ori et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- cGAS surveillance of micronuclei links genome instability to innate immunity
- (2017) Karen J. Mackenzie et al. NATURE
- Mitotic progression following DNA damage enables pattern recognition within micronuclei
- (2017) Shane M. Harding et al. NATURE
- Cytoplasmic chromatin triggers inflammation in senescence and cancer
- (2017) Zhixun Dou et al. NATURE
- Innate immune sensing of cytosolic chromatin fragments through cGAS promotes senescence
- (2017) Selene Glück et al. NATURE CELL BIOLOGY
- cGAS is essential for cellular senescence
- (2017) Hui Yang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tumor-Associated Macrophages Suppress the Cytotoxic Activity of Antimitotic Agents
- (2017) Oakley C. Olson et al. Cell Reports
- The Cell Nucleus Serves as a Mechanotransducer of Tissue Damage-Induced Inflammation
- (2016) Balázs Enyedi et al. CELL
- Activation of STING-Dependent Innate Immune Signaling By S-Phase-Specific DNA Damage in Breast Cancer
- (2016) Eileen E. Parkes et al. JNCI-Journal of the National Cancer Institute
- Activation of STING-Dependent Innate Immune Signaling By S-Phase-Specific DNA Damage in Breast Cancer
- (2016) Eileen E. Parkes et al. JNCI-Journal of the National Cancer Institute
- Activation of IFN/STAT1 signalling predicts response to chemotherapy in oestrogen receptor-negative breast cancer
- (2015) Marie-Emmanuelle Legrier et al. BRITISH JOURNAL OF CANCER
- Spindle-to-cortex communication in cleaving, polyspermic Xenopus eggs
- (2015) Christine M. Field et al. MOLECULAR BIOLOGY OF THE CELL
- Chromothripsis from DNA damage in micronuclei
- (2015) Cheng-Zhong Zhang et al. NATURE
- In vivo cell-cycle profiling in xenograft tumors by quantitative intravital microscopy
- (2015) Deepak R Chittajallu et al. NATURE METHODS
- Immune-mediated mechanisms influencing the efficacy of anticancer therapies
- (2015) Seth B. Coffelt et al. TRENDS IN IMMUNOLOGY
- Post-slippage multinucleation renders cytotoxic variation in anti-mitotic drugs that target the microtubules or mitotic spindle
- (2014) Yanting Zhu et al. CELL CYCLE
- Topical pharmacotherapy for skin cancer
- (2014) Giuseppe Micali et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Depletion of the protein kinase VRK1 disrupts nuclear envelope morphology and leads to BAF retention on mitotic chromosomes
- (2014) Tyler P. Molitor et al. MOLECULAR BIOLOGY OF THE CELL
- How Taxol/paclitaxel kills cancer cells
- (2014) Beth A. Weaver MOLECULAR BIOLOGY OF THE CELL
- The cGAS-cGAMP-STING Pathway of Cytosolic DNA Sensing and Signaling
- (2014) Xin Cai et al. MOLECULAR CELL
- Hydrolysis of 2′3′-cGAMP by ENPP1 and design of nonhydrolyzable analogs
- (2014) Lingyin Li et al. Nature Chemical Biology
- Cytotoxicity of Paclitaxel in Breast Cancer Is due to Chromosome Missegregation on Multipolar Spindles
- (2014) L. M. Zasadil et al. Science Translational Medicine
- Dnase2a Deficiency Uncovers Lysosomal Clearance of Damaged Nuclear DNA via Autophagy
- (2014) Yuk Yuen Lan et al. Cell Reports
- Anticancer Flavonoids Are Mouse-Selective STING Agonists
- (2013) Sujeong Kim et al. ACS Chemical Biology
- Antimitotic drugs in cancer chemotherapy: Promises and pitfalls
- (2013) Isabel Marzo et al. BIOCHEMICAL PHARMACOLOGY
- Catastrophic Nuclear Envelope Collapse in Cancer Cell Micronuclei
- (2013) Emily M. Hatch et al. CELL
- Mitosis and apoptosis: how is the balance set?
- (2013) Caroline H Topham et al. CURRENT OPINION IN CELL BIOLOGY
- Mouse, but not Human STING, Binds and Signals in Response to the Vascular Disrupting Agent 5,6-Dimethylxanthenone-4-Acetic Acid
- (2013) J. Conlon et al. JOURNAL OF IMMUNOLOGY
- Neutralizing Tumor-Promoting Chronic Inflammation: A Magic Bullet?
- (2013) L. M. Coussens et al. SCIENCE
- Phase I study of barasertib (AZD1152), a selective inhibitor of Aurora B kinase, in patients with advanced solid tumors
- (2012) Gary K. Schwartz et al. INVESTIGATIONAL NEW DRUGS
- DNA breaks and chromosome pulverization from errors in mitosis
- (2012) Karen Crasta et al. NATURE
- Taxane-Induced Blockade to Nuclear Accumulation of the Androgen Receptor Predicts Clinical Responses in Metastatic Prostate Cancer
- (2011) M. S. Darshan et al. CANCER RESEARCH
- Navitoclax (ABT-263) Accelerates Apoptosis during Drug-Induced Mitotic Arrest by Antagonizing Bcl-xL
- (2011) J. Shi et al. CANCER RESEARCH
- DNA Alkylating Therapy Induces Tumor Regression through an HMGB1-Mediated Activation of Innate Immunity
- (2011) J. L. Guerriero et al. JOURNAL OF IMMUNOLOGY
- The proliferation rate paradox in antimitotic chemotherapy
- (2011) Timothy J. Mitchison MOLECULAR BIOLOGY OF THE CELL
- Mitosis is not a key target of microtubule agents in patient tumors
- (2011) Edina Komlodi-Pasztor et al. Nature Reviews Clinical Oncology
- A phase I study of ispinesib, a kinesin spindle protein inhibitor, administered weekly for three consecutive weeks of a 28-day cycle in patients with solid tumors
- (2010) Howard A. Burris et al. INVESTIGATIONAL NEW DRUGS
- K858, a Novel Inhibitor of Mitotic Kinesin Eg5 and Antitumor Agent, Induces Cell Death in Cancer Cells
- (2009) R. Nakai et al. CANCER RESEARCH
- Cells satisfy the mitotic checkpoint in Taxol, and do so faster in concentrations that stabilize syntelic attachments
- (2009) Zhenye Yang et al. JOURNAL OF CELL BIOLOGY
- Cancer Cells Display Profound Intra- and Interline Variation following Prolonged Exposure to Antimitotic Drugs
- (2008) Karen E. Gascoigne et al. CANCER CELL
- Cell Type Variation in Responses to Antimitotic Drugs that Target Microtubules and Kinesin-5
- (2008) J. Shi et al. CANCER RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started